Kul Cinar, Ovgu;
Putland, Amber;
Wynne, Karen;
Eleftheriou, Despina;
Brogan, Paul A;
(2022)
Hereditary Systemic Autoinflammatory Diseases: Therapeutic Stratification.
Frontiers in Pediatrics
, 10
, Article 867679. 10.3389/fped.2022.867679.
Preview |
Text
Brogan_fped-10-867679.pdf Download (3MB) | Preview |
Abstract
Hereditary systemic autoinflammatory diseases (SAIDs) are rare, often severe conditions characterised by mutations in the key regulators of innate immune responses. Dramatic advances in the molecular genetics and next-generation sequencing in the past decade enabled identification of novel mutations that play a pivotal role in the mechanistic pathways of inflammation. Although genetic testing may not always provide straightforward guidance in diagnosis and clinical decision making, through translational research, it sheds light into molecular immunopathogenesis, particularly in IL-1 inflammasome and cytokine signalling pathways. These remarkable insights provided a better understanding of autoinflammatory conditions and their association with the innate and adaptive immune systems, as well as leading to development of cytokine-targetted biologic treatments. Use of targetted therapeutics not only helps control disease flares, reduce acute-phase responses and prevent devastating complications such as amyloidosis, but also improves health-related quality of lives and support patients to pursue almost a normal life. Herein, we discuss the commonest monogenic SAIDs, describe their immunopathology, and summarise the approaches in the management and targetted treatment of these conditions, including presentation of novel data based on a cohort of children with these rare diseases from a single quaternary referral centre in London.
| Type: | Article |
|---|---|
| Title: | Hereditary Systemic Autoinflammatory Diseases: Therapeutic Stratification |
| Location: | Switzerland |
| Open access status: | An open access version is available from UCL Discovery |
| DOI: | 10.3389/fped.2022.867679 |
| Publisher version: | https://doi.org/10.3389/fped.2022.867679 |
| Language: | English |
| Additional information: | © 2022 Kul Cinar, Putland, Wynne, Eleftheriou and Brogan. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
| Keywords: | IL-1 inhibitors, JAK 1/2 inhibitors, genomics, innate immunity, interferonopathies, periodic fever, systemic autoinflammation |
| UCL classification: | UCL UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Population Health Sciences > UCL GOS Institute of Child Health > Infection, Immunity and Inflammation Dept UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Population Health Sciences > UCL GOS Institute of Child Health UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences |
| URI: | https://discovery.ucl.ac.uk/id/eprint/10148710 |
Archive Staff Only
 |
View Item |
